国: イスラエル
言語: ヘブライ語
ソース: Ministry of Health
EVEROLIMUS 0.25 MG
NOVARTIS PHARMA SERVICES AG
L04AA18
TABLETS DISPERSIBLE
PER OS
NOVARTIS PHARMA STEIN AG, SWITZERLAND
EVEROLIMUS
Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.
2010-02-01